April 30, 2006

Odd effects put focus on sleep drugs

Reports about patients who eat, cook and even drive in their sleep after taking Ambien have raised questions about the safety of the insomnia drug and have led some to criticize the nation’s growing use of …


From Insomnia News

April 29, 2006

Mother pleads not guilty to lacing baby formula

A Prairie du Chien, Wis., woman accused of lacing her infant daughter’s baby formula with a powerful sleeping medication pleaded not guilty to felony child abuse and drug charges Friday.


From Insomnia News

April 25, 2006

Sepracor Shares Have Room For Downside

Prudential Equity Group maintained an “underweight” rating on specialty pharmaceutical firm Sepracor after the company reported disappointing first-quarter results on Tuesday morning.


From Insomnia News

Doctors wake up to sleeping pill risks …

The National Institutes of Health has called for more research into insomnia treatments amid reports of people who eat, cook and drive in their sleep.


From Insomnia News

Doctors wake up to sleeping pill risks

The National Institutes of Health has called for more research into insomnia treatments amid reports of people who eat, cook and drive in their sleep.


From Insomnia News

April 24, 2006

Terminally Disclaimed Patents Not Barred from Obtaining a 156 Extension

A federal District Court ruled that a terminal disclaimer does not negate Patent Term Extension.


From Insomnia News

Getting A Good Night’s Sleep Without Using Drugs

BOSTON Experts are sounding a wake-up call about the nation’s growing use of sleep medications, but there are some drug-free ways to help you get a better night’s sleep.


From Insomnia News

Sepracor Sneaks In Lunesta Reminder Ad

Has Sepracor decided to sneak in one or two more Lunesta “reminder” ads on TV despite its announcement last year that it has “adopted’ PhRMA’s Guiding Principles for DTC advertising, which put a kibosh on such …


From Insomnia News

April 19, 2006

Acadia’s ACP-103 improves sleep

Acadia said Wednesday its potential insomnia treatment, ACP-103, improved sleep in a proof-of-concept clinical trial.


From Insomnia News

Acadia study shows drug lengthens sleep

Drug developer Acadia Pharmaceuticals Inc. said Wednesday that early results from a clinical trial showed its experimental insomnia treatment significantly increased periods of deep sleep in patients.


From Insomnia News

Next Page »